Medical Economics Newsletter

To view this email as a web page, click here.

Sometimes, the disease wins and physicians lose

A rare disease. A shattered family. A medical team with no answers. Sometimes the worst outcomes fuel the greatest desire for a cure.

Will Trump's drug plan truly reduce costs?

Earlier this month, the U.S. Health and Human Services Department unveiled "American Patients First," President Trump's blueprint to lower drug prices and reduce out-of-pocket costs for patients.

Take our poll

FROM OUR LATEST ISSUE

Check out our latest issue, featuring:

• How to discuss cost of care
• PCPs’ role in diagnosing rheumatoid arthritis
• The future of health IT

Popular online this week

Physician replacements affecting vulnerable patient populations

Addressing social determinants of health the key to better compliance

Charge-capture software can increase practice revenue

Two paths ahead for MACRA and QPP

More providers than ever before are getting a full pass on pay-for-performance in 2018, and even those that are required to participate have a path that is only marginally more difficult than this year.

Is all that too good to be true?

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.